SCHEMBL17819683

SCHEMBL17819683

CON(C)C(=O)c1cnc(N(C)C)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SIRT6 Q8N6T7 1/20 0.35
OXTR P30559 7/20 0.34
AVPR1A P37288 3/20 0.34
CLK1 P49759 1/20 0.34
DYRK1A Q13627 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
MLYCD O95822 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
MAPK1 P28482 2/20 0.32
ICAM1 P05362 1/20 0.32
SELE P16581 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.31
POLB P06746 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2882770 0.82 KMT2A (0.49) MEN1KMT2AOXTRAVPR1ATDP1
SCHEMBL2304361 0.79 SIRT6 (0.50) MEN1KMT2ASIRT6OXTRAVPR1A
SCHEMBL16601358 0.79 SIRT6 (0.59) MEN1KMT2ASIRT6OXTRAVPR1A
SCHEMBL17161002 0.79 MAPK1 (0.49) SIRT6PKMMAPK1POLBKDM4E
SCHEMBL1760211 0.76 KDM4E (0.44) MEN1KMT2ASIRT6TDP1PKM
SCHEMBL17819949 0.76 KCNJ1 (0.41) SIRT6KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL30874226 0.76 KDM4E (0.44) MEN1KMT2ASIRT6TDP1PKM
SCHEMBL24774974 0.76 MLYCD (0.40) MEN1KMT2ASIRT6OXTRAVPR1A
SCHEMBL30108431 0.76 MLYCD (0.40) MEN1KMT2ASIRT6OXTRAVPR1A
SCHEMBL7139611 0.75 P4HTM (0.40) OXTRAVPR1AMLYCDTDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3042900-B1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2020-09-23 EP disclosed
EP-3042900-B1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2020-09-23 EP disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
EP-3042900-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF Fujifilm Corporation (JP) 2016-07-13 EP disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF PRMT7, RBBP7, RER1 MEN1 772/4885KMT2A 1128/4885SIRT6 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.